LIBERATORE, Carmine
 Distribuzione geografica
Continente #
AS - Asia 484
NA - Nord America 459
EU - Europa 252
SA - Sud America 90
AF - Africa 13
OC - Oceania 1
Totale 1.299
Nazione #
US - Stati Uniti d'America 432
SG - Singapore 210
CN - Cina 117
IT - Italia 95
VN - Vietnam 75
BR - Brasile 71
RU - Federazione Russa 55
HK - Hong Kong 23
FI - Finlandia 18
DE - Germania 17
GB - Regno Unito 13
AT - Austria 12
MX - Messico 12
CA - Canada 11
IN - India 11
PL - Polonia 9
BD - Bangladesh 8
FR - Francia 7
AR - Argentina 6
NL - Olanda 6
TR - Turchia 6
JP - Giappone 5
LT - Lituania 5
PK - Pakistan 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BE - Belgio 4
EC - Ecuador 4
ES - Italia 4
UZ - Uzbekistan 4
KR - Corea 3
SE - Svezia 3
VE - Venezuela 3
CL - Cile 2
CO - Colombia 2
ID - Indonesia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GD - Grenada 1
HN - Honduras 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
LK - Sri Lanka 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 1.299
Città #
Singapore 160
San Jose 97
Dallas 73
Ashburn 49
Pescara 30
Ho Chi Minh City 26
Beijing 24
Los Angeles 24
Hong Kong 23
Hanoi 19
Council Bluffs 16
New York 12
Orem 11
São Paulo 11
Lappeenranta 10
Santa Clara 10
Shenzhen 10
Hefei 9
Milan 9
Helsinki 8
Nuremberg 8
The Dalles 8
Tongling 8
Buffalo 7
Mexico City 7
Warsaw 7
Chennai 6
Redondo Beach 6
Manchester 5
Moscow 5
Vienna 5
Ankara 4
Atlanta 4
Chicago 4
Denver 4
Frankfurt am Main 4
Haiphong 4
Houston 4
Lauterbourg 4
Montreal 4
Tokyo 4
Amsterdam 3
Brooklyn 3
Da Nang 3
Florence 3
Francavilla al Mare 3
Hải Dương 3
Jeddah 3
Johannesburg 3
London 3
Mumbai 3
Phoenix 3
Querétaro 3
Quito 3
Seattle 3
Seoul 3
Tashkent 3
Belo Horizonte 2
Buenos Aires 2
Caracas 2
Caxias do Sul 2
Cepagatti 2
Charlotte 2
Ghent 2
Hove 2
João Pessoa 2
Lahore 2
Massa Lombarda 2
Padua 2
Poplar 2
Porto Alegre 2
Ribeirão Preto 2
Rio de Janeiro 2
Riyadh 2
Rome 2
San Francisco 2
Stockholm 2
Vila Velha 2
Viçosa 2
Xi'an 2
Antofagasta 1
Aquiraz 1
Areado 1
Ascoli Piceno 1
Auckland 1
Baku 1
Bari 1
Barrancabermeja 1
Bauru 1
Belgrade 1
Betim 1
Bologna 1
Boston 1
Brasília 1
Buon Ma Thuot 1
Bắc Giang 1
Bến Tre 1
Cabo Frio 1
Caetité 1
Calgary 1
Totale 857
Nome #
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation 111
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 109
Long-Term Survival with Multiple Myeloma: An Italian Experience 106
Allogeneic stem cell transplantation in multiple myeloma: is there still a place? 84
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts 74
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB 70
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 69
Immune Reconstitution-Based Score for Risk Stratification of Chronic Graft-Versus-Host Disease Patients 69
Higher cyclophosphamide dose grants optimal stem-cell collection after daratumumab-based induction in multiple myeloma 66
Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation 65
Cytomegalovirus infection after autologous transplantation in patients with multiple myeloma exposed to daratumumab 65
Novel Approaches to Treatment of Acute Myeloid Leukemia Relapse Post Allogeneic Stem Cell Transplantation 63
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 62
Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia 61
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 50
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 44
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control 41
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 36
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience 35
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice? 34
Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy 32
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 22
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone 6
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations 5
Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience 4
REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials 3
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application 1
Recurrent cytokine release syndrome in patients receiving bispecific antibody therapy for multiple myeloma: a case series 1
Totale 1.388
Categoria #
all - tutte 4.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202429 1 0 0 3 0 0 6 7 7 1 1 3
2024/2025334 8 23 20 9 20 50 42 22 30 24 28 58
2025/20261.025 53 48 123 157 118 58 165 87 113 103 0 0
Totale 1.388